(Press-News.org) Research from the University of Southampton has shown a drug, used in combination with chemotherapy to treat advanced colorectal cancer, is not effective in some settings, and indeed may result in more rapid cancer progression.
The New EPOC study, published in The Lancet Oncology and funded by Cancer Research UK, evaluated whether the drug cetuximab and chemotherapy together worked better than chemotherapy alone as a treatment in addition to surgery for people with bowel cancer that had spread to the liver but could be surgically removed. In the trial patients either received chemotherapy on its own or chemotherapy combined with cetuximab. Patients received their specified treatment for 12 weeks. They then had surgery and followed by their specified treatment for another 12 weeks. Patients were then monitored via CT or MRI scans.
The researchers found that adding cetuximab to chemotherapy did not help this group of people. Analysis looked at how long people in each group were living without any sign of their cancer getting worse. They found this was on average 14.1 months in the group having chemotherapy and cetuximab compared to 20.5 months in the group having chemotherapy alone.
John Primrose, Professor of Surgery at the University of Southampton, comments: "These results were unexpected. Cetuximab is already approved by NICE alongside chemotherapy for people who had bowel cancer that had spread to the liver if the oncologist and liver surgeon thought this would enable the patient to have a liver operation. The cetuximab and chemotherapy combination is also used successfully in patients whose disease cannot be operated on at all. Our trial tested it in people who had cancer spread to the liver who were suitable for surgery from the outset, a similar group, but for these patients it seems to have an adverse effect. More research is needed to understand this surprising result."
Professor Primrose, also a consultant surgeon at Southampton General Hospital, adds: "These are very important data and we would like to thank the patients and relatives of patients those who took part in this trial, as well as the many clinicians in the UK who participated. Our results demonstrate the importance of clinical trials to ensure patients with cancer receive the best of treatment for their condition."
INFORMATION: END
Unexpected results in cancer drug trial
2014-04-08
ELSE PRESS RELEASES FROM THIS DATE:
Scalable CVD process for making 2-D molybdenum diselenide
2014-04-08
Nanoengineering researchers at Rice University and Nanyang Technological University in Singapore have unveiled a potentially scalable method for making one-atom-thick layers of molybdenum diselenide -- a highly sought semiconductor that is similar to graphene but has better properties for making certain electronic devices like switchable transistors and light-emitting diodes.
The method for making two-dimensional molybdenum diselenide uses a technique known as chemical vapor deposition (CVD) and is described online in a new paper in the American Chemical Society journal ...
Study: Black carbon is ancient by the time it reaches seafloor
2014-04-08
A fraction of the carbon that finds its way into Earth's oceans -- the black soot and charcoal residue of fires -- stays there for thousands for years, and a new first-of-its-kind analysis shows how some black carbon breaks away and hitches a ride to the ocean floor on passing particles.
The study by scientists from Rice University, the University of California, Irvine, and the University of South Carolina offers the first detailed analysis of how black carbon gets into deep ocean sediments, as well as an accounting of the types and amounts of black carbon found in those ...
Graphene nanoribbons as electronic switches
2014-04-08
One of graphene's most sought-after properties is its high conductivity. Argentinian and Brazilian physicists have now successfully calculated the conditions of the transport, or conductance mechanisms, in graphene nanoribbons. The results, recently published in a paper in EPJ B, yield a clearer theoretical understanding of conductivity in graphene samples of finite size, which have applications in externally controlled electronic devices.
When the conductivity is high, the electrons, carriers of electrical current, are minimally hampered during transport through graphene. ...
Scientists use Google Glass to map the future of medical testing (video)
2014-04-08
WASHINGTON, April 8, 2014 — A team of researchers at UCLA has transformed Google Glass into powerful, wearable medical testing laboratory. Aydogan Ozcan and his team developed an application that reads dozens of different types of diagnostic tests for malaria, prostate cancer and HIV, to name a few. Glass uploads the results to secure servers and provides anonymous data to epidemiologists. In the American Chemical Society's (ACS') newest Breakthrough Science video, Ozcan demonstrates how the app works, and explains the broad impact it could have on medicine. The video is ...
UC geographers develop a system to track the dynamics of drought
2014-04-08
University of Cincinnati researchers are at work tracking drought patterns across the United States. Qiusheng Wu, a doctoral student and research assistant for the UC Department of Geography, and Hongxing Liu, a UC professor and head of the Department of Geography, will present details this week at the annual meeting of the Association of American Geographers (AAG) in Tampa, Fla.
To trace the dynamics around agricultural drought, the UC researchers implemented an Event-based Spatial-Temporal Data Model (ESTDM) to detect, track and monitor conditions. The framework organizes ...
Back to basics: Redesigning systems of care for older adults with Alzheimer's disease
2014-04-08
INDIANAPOLIS -- The number of older adults with dementia in the United States is forecast to more than double over the next 40 years. Caring for these individuals will have a significant impact on caregivers as well as the health care system and its workforce.
In a paper published in the April issue of the peer-reviewed journal Health Affairs, Regenstrief Institute investigator Christopher M. Callahan, M.D., founding director of the Indiana University Center for Aging Research, reviews two new dementia care models that seek to decrease stress for caregivers, reduce health ...
Kitchens are a source of multi-drug resistant bacteria
2014-04-08
CHICAGO (April 8, 2014) – After handling raw poultry, hands of food preparers and cutting boards remain a source of transmission for multi-drug resistant bacteria, such as E. coli that produce extended-spectrum beta-lactamases (ESBLs). The study of household and hospital kitchens was published in the May issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
"The spread of multi-drug resistant bacteria has been associated with the hospital setting, but these findings suggest that transmission of drug-resistant ...
Expert guidance highlights practices to reduce prevalence of catheter-associated UTIs
2014-04-08
CHICAGO (April 8, 2014) – New expert guidance highlights strategies for implementing and prioritizing efforts to prevent catheter-associated urinary tract infections (CAUTI) in hospitals. The practice recommendations, published in the May issue of Infection Control and Hospital Epidemiology, are the first in a series to be published over several months sharing evidence-based strategies to help healthcare professionals effectively control and prevent the spread of healthcare-associated infections (HAIs).
A Compendium of Strategies to Prevent Healthcare-Associated Infections ...
Domain walls in nanowires cleverly set in motion
2014-04-08
Researchers at Johannes Gutenberg University Mainz (JGU) have achieved a major breakthrough in the development of methods of information processing in nanomagnets. Using a new trick, they have been able to induce synchronous motion of the domain walls in a ferromagnetic nanowire. This involved applying a pulsed magnetic field that was perpendicular to the plane of the domain walls. "This is a radically new solution," explained Professor Mathias Kläui of the Institute of Physics of Johannes Gutenberg University Mainz. "It enables us to move domain walls synchronously over ...
Montreal researchers explain how our immune system kills abnormal blood cells
2014-04-08
A team of researchers at the IRCM, led by André Veillette, MD, explains how our immune system kills abnormal blood cells. Their discovery, recently published in the Journal of Experimental Medicine, could eventually lead to new treatment avenues for leukemia, lymphoma and certain types of infectious viral diseases.
"Our team is studying how natural killer cells can eliminate abnormal hematopoietic (blood) cells," explains Dr. Veillette, Director of the Molecular Oncology research unit at the IRCM. "NK (natural killer) cells are crucial to the immune system and play a ...